Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CTNMCTNM
9 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CONTINEUM THERAPEUTICS INC

NORTHERN TRUST CORP holds 277,804 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $4.6M as of 2026-Q2. The position was increased (+321.4% shares). CTNM represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$4.6M

Current Shares

277,804

Total Value Change

+$4.2M

Total Shares Change

+258,427

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
277,804
+321.4%
$4.6M0.0%$16.39
43
2026-Q1
Increased
65,928
+22.4%
$861,0200.0%$14.10
30
2025-Q4
Increased
53,876
+10.0%
$615,8030.0%$11.40
27
2025-Q3
Increased
48,963
+94.5%
$575,3150.0%$11.82
39
2025-Q2
Decreased
25,169
-69.9%
$99,9210.0%$4.11
0
2025-Q1
Decreased
83,626
-6.3%
$583,7090.0%$7.07
0
2024-Q4
Increased
89,262
+42.3%
$1.3M0.0%$14.47
34
2024-Q3
Increased
62,717
+223.7%
$1.2M0.0%$18.84
41
2024-Q2
New
19,377
-
$341,2290.0%$17.61
33

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used